397 related articles for article (PubMed ID: 11504747)
1. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma.
Chia SK; Wykoff CC; Watson PH; Han C; Leek RD; Pastorek J; Gatter KC; Ratcliffe P; Harris AL
J Clin Oncol; 2001 Aug; 19(16):3660-8. PubMed ID: 11504747
[TBL] [Abstract][Full Text] [Related]
2. The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosis.
Colpaert CG; Vermeulen PB; Fox SB; Harris AL; Dirix LY; Van Marck EA
Breast Cancer Res Treat; 2003 Sep; 81(2):137-47. PubMed ID: 14572156
[TBL] [Abstract][Full Text] [Related]
3. HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome.
Trastour C; Benizri E; Ettore F; Ramaioli A; Chamorey E; Pouysségur J; Berra E
Int J Cancer; 2007 Apr; 120(7):1451-8. PubMed ID: 17245699
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer.
Hussain SA; Ganesan R; Reynolds G; Gross L; Stevens A; Pastorek J; Murray PG; Perunovic B; Anwar MS; Billingham L; James ND; Spooner D; Poole CJ; Rea DW; Palmer DH
Br J Cancer; 2007 Jan; 96(1):104-9. PubMed ID: 17213826
[TBL] [Abstract][Full Text] [Related]
5. CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance.
Brennan DJ; Jirstrom K; Kronblad A; Millikan RC; Landberg G; Duffy MJ; Rydén L; Gallagher WM; O'Brien SL
Clin Cancer Res; 2006 Nov; 12(21):6421-31. PubMed ID: 17085655
[TBL] [Abstract][Full Text] [Related]
6. [Significance of carbonic anhydrase IX protein expression in molecular subtyping of breast cancers].
Li MP; Ren LF; Cai HG; Yang HY; Lu B; Zhang P; Bao L
Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):182-5. PubMed ID: 23769438
[TBL] [Abstract][Full Text] [Related]
7. Biodistribution and pharmacokinetics of 125I-labeled monoclonal antibody M75 specific for carbonic anhydrase IX, an intrinsic marker of hypoxia, in nude mice xenografted with human colorectal carcinoma.
Chrastina A; Závada J; Parkkila S; Kaluz S; Kaluzová M; Rajcáni J; Pastorek J; Pastoreková S
Int J Cancer; 2003 Jul; 105(6):873-81. PubMed ID: 12767076
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of carbonic anhydrase IX (CA-IX), endoglin (CD105) and 8-hydroxy-2'-deoxyguanosine (8-OHdG) in breast cancer patients.
Beketic-Oreskovic L; Ozretic P; Rabbani ZN; Jackson IL; Sarcevic B; Levanat S; Maric P; Babic I; Vujaskovic Z
Pathol Oncol Res; 2011 Sep; 17(3):593-603. PubMed ID: 21249485
[TBL] [Abstract][Full Text] [Related]
9. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
Hui EP; Chan AT; Pezzella F; Turley H; To KF; Poon TC; Zee B; Mo F; Teo PM; Huang DP; Gatter KC; Johnson PJ; Harris AL
Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.
Schrijvers ML; van der Laan BF; de Bock GH; Pattje WJ; Mastik MF; Menkema L; Langendijk JA; Kluin PM; Schuuring E; van der Wal JE
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):161-9. PubMed ID: 18722267
[TBL] [Abstract][Full Text] [Related]
11. Expression of hypoxic marker carbonic anhydrase IX predicts poor prognosis in resectable hepatocellular carcinoma.
Huang WJ; Jeng YM; Lai HS; Fong IU; Sheu FY; Lai PL; Yuan RH
PLoS One; 2015; 10(3):e0119181. PubMed ID: 25738958
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer.
Swinson DE; Jones JL; Richardson D; Wykoff C; Turley H; Pastorek J; Taub N; Harris AL; O'Byrne KJ
J Clin Oncol; 2003 Feb; 21(3):473-82. PubMed ID: 12560438
[TBL] [Abstract][Full Text] [Related]
13. Immunotargeting of human cervical carcinoma xenograft expressing CA IX tumor-associated antigen by 125I-labeled M75 monoclonal antibody.
Chrastina A; Pastoreková S; Pastorek J
Neoplasma; 2003; 50(1):13-21. PubMed ID: 12687273
[TBL] [Abstract][Full Text] [Related]
14. Metabolism-related proteins are differentially expressed according to the molecular subtype of invasive breast cancer defined by surrogate immunohistochemistry.
Choi J; Jung WH; Koo JS
Pathobiology; 2013; 80(1):41-52. PubMed ID: 22832328
[TBL] [Abstract][Full Text] [Related]
15. Expression of new prognostic markers, peripheral-type benzodiazepine receptor and carbonic anhydrase IX, in human breast and ovarian carcinoma cell lines.
Hunakova L; Bodo J; Chovancova J; Sulikova G; Pastorekova S; Sedlak J
Neoplasma; 2007; 54(6):541-8. PubMed ID: 17949239
[TBL] [Abstract][Full Text] [Related]
16. Carbonic anhydrase IX: a promising diagnostic and prognostic biomarker in breast carcinoma.
Furjelová M; Kovalská M; Jurková K; Horáček J; Carbolová T; Adamkov M
Acta Histochem; 2014 Jan; 116(1):89-93. PubMed ID: 23816158
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON.
Jonathan RA; Wijffels KI; Peeters W; de Wilde PC; Marres HA; Merkx MA; Oosterwijk E; van der Kogel AJ; Kaanders JH
Radiother Oncol; 2006 Jun; 79(3):288-97. PubMed ID: 16730088
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification.
Betof AS; Rabbani ZN; Hardee ME; Kim SJ; Broadwater G; Bentley RC; Snyder SA; Vujaskovic Z; Oosterwijk E; Harris LN; Horton JK; Dewhirst MW; Blackwell KL
Br J Cancer; 2012 Feb; 106(5):916-22. PubMed ID: 22333602
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.
Bache M; Reddemann R; Said HM; Holzhausen HJ; Taubert H; Becker A; Kuhnt T; Hänsgen G; Dunst J; Vordermark D
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1481-7. PubMed ID: 17056190
[TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase IX, a marker of hypoxia: correlation with clinical outcome in transitional cell carcinoma of the bladder.
Hussain SA; Palmer DH; Ganesan R; Hiller L; Gregory J; Murray PG; Pastorek J; Young L; James ND
Oncol Rep; 2004 May; 11(5):1005-10. PubMed ID: 15069539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
